The federal government's $92-million investment in adMare Bioinnovations' spurred the creation of 39 Canadian life sciences companies, says adMare CEO Gordon McCauley. These companies have generated $2.5 billion in risk capital and 1,000 jobs, addressing a critical gap in early-stage funding for the life sciences and keeping more value from Canadian research within the country, he says.
| Organizations: | |
| People: | |
| Topics: |